Source: PGIM, Bloomberg as of 6/30/2025. Past performance is not indicative of future results. The ECB's policy flexibility stands in contrast with the Fed. An airgap remains between recent U.S.
The Fund lost value but held up significantly better than the Index during the quarter. Stock selection within biotechnology, pharmaceuticals, and life sciences tools & services, along with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback